Literature DB >> 6294446

Status of the red cell Na,K-pump in hyper- and hypothyroidism.

M DeLuise, J S Flier.   

Abstract

To investigate the status of the sodium-potassium pump in cells of human subjects with abnormal thyroid function, we measured the number of pump units as well as the cation transport activity of the pump in erythrocytes from 23 hyperthyroid and 7 hypothyroid patients. It was found that the number of Na+-K+-ATPase units in erythrocytes (as measured by ouabain binding) was significantly reduced in hyperthyroidism (mean 36% below controls, p less than 0.001). The rate of rubidium uptake by the same cells was also reduced, but to a smaller extent (mean 9%, p less than 0.02). These changes were reversible with control of the hyperthyroidism. Hypothyroid individuals showed changes in erythrocyte Na+-K+ pump which were in the opposite direction to those seen in hyperthyroidism. It is concluded that thyroid hormone exerts a marked negative influence on the number of Na+-K+ pump units in one easily available human cell type. The direction of the effect suggests a complex relationship between thyroid hormone and the level of the Na,K-ATPase in any one tissue. Whatever the cellular mechanism responsible for the effects observed in the red cell, these changes should provide a measure of thyroid hormone action at a cellular level and this may prove useful in the study of thyroid hormone physiology in man.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6294446     DOI: 10.1016/0026-0495(83)90151-8

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  7 in total

Review 1.  The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis.

Authors:  H C Ford; J M Carter
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

2.  Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy.

Authors:  Rohit Anthony Sinha; Seo-Hee You; Jin Zhou; Mobin M Siddique; Boon-Huat Bay; Xuguang Zhu; Martin L Privalsky; Sheue-Yann Cheng; Robert D Stevens; Scott A Summers; Christopher B Newgard; Mitchell A Lazar; Paul M Yen
Journal:  J Clin Invest       Date:  2012-06-11       Impact factor: 14.808

3.  Na+K+ATPase activity and ouabain binding sites in erythrocytes in hyperthyroidism before and after treatment.

Authors:  C De Riva; S Chen; F Virgili; F Frigato
Journal:  J Endocrinol Invest       Date:  1992-05       Impact factor: 4.256

4.  Alterations in osmotic fragility of the red blood cells in hypo- and hyperthyroid patients.

Authors:  S Zahedi Asl; N Khalili Brojeni; A Ghasemi; F Faraji; M Hedayati; F Azizi
Journal:  J Endocrinol Invest       Date:  2009-01       Impact factor: 4.256

5.  The Effects of Altered Membrane Cholesterol Levels on Sodium Pump Activity in Subclinical Hypothyroidism.

Authors:  Suparna Roy; Anindya Dasgupta
Journal:  Endocrinol Metab (Seoul)       Date:  2017-02-28

Review 6.  Erythrocyte Deformability and Na,K-ATPase Activity in Various Pathophysiological Situations and Their Protection by Selected Nutritional Antioxidants in Humans.

Authors:  Jana Radosinska; Norbert Vrbjar
Journal:  Int J Mol Sci       Date:  2021-11-03       Impact factor: 5.923

7.  Red cell sodium and ionic fluxes in patients with hyper- and hypothyroidism.

Authors:  Y S Yoon; K S Hong; B Y Cha; Y W Kim; K W Lee; H Y Son; S K Kang; B K Bang; H R Moon
Journal:  Korean J Intern Med       Date:  1989-01       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.